NeoGenomics
259 hedge funds and large institutions have $1.74B invested in NeoGenomics in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 70 increasing their positions, 93 reducing their positions, and 32 closing their positions.
273% more call options, than puts
Call options by funds: $10.2M | Put options by funds: $2.74M
0% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 32
2% less funds holding
Funds holding: 263 → 259 (-4)
2.35% less ownership
Funds ownership: 100.76% → 98.42% (-2.3%)
14% less capital invested
Capital invested by funds: $2.02B → $1.74B (-$278M)
25% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 93
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$16.5M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$12.7M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$10.8M |
| 4 |
FAM
Fred Alger Management
New York
|
-$7.16M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$4.61M |
NEO Hedge Fund Activity: Q2 2024 in Review
259 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2024, worth a combined $1.74B — down 14% from $2.02B a quarter earlier.
Fund positioning in NEO was balanced in Q2 2024: 32 funds opened new positions, 32 closed out, 70 added to existing stakes and 93 trimmed.
The largest buyer was Schroder Investment Management Group, adding an estimated $15.5M. The largest seller was Point72 Asset Management, cutting an estimated $16.5M.
- 259 institutional investors held NeoGenomics (NEO) as of Q2 2024, down from 263 in Q1 2024.
- Funds reported $1.74B of NeoGenomics stock for Q2 2024, down 14% quarter-over-quarter.
- 32 funds opened new NeoGenomics positions in Q2 2024 and 32 closed out, a net change of 0 holders.
- The largest NeoGenomics buyer in Q2 2024 was Schroder Investment Management Group, an estimated $15.5M added.
- The largest NeoGenomics seller in Q2 2024 was Point72 Asset Management, an estimated $16.5M sold.
Based on aggregated 13F filings for Q2 2024.